Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROstate CAncer Real World Evidence Registry: RECURRENT AND METASTATIC PROSTATE CANCER

NCT06835218 is registered in ClinicalTrials.gov with UroTrials Company (GmbH) as lead sponsor.

NCT NCT06835218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06835218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROstate CAncer Real World Evidence Registry: RECURRENT AND METASTATIC PROSTATE CANCER
Lead sponsor
UroTrials Company (GmbH)
Phase
Observational
Overall status
Recruiting
Start date
January 29, 2024
Completion date
December 31, 2032
Enrollment
5,000 (estimated)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

biochemical recurrence of malignant neoplasm of prostate, metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer (mhspc), non-metastatic castration-resistant prostate cancer, prostate cancer